Evaluation of mitomycin C in reducing postoperative adhesions in strabismus surgery.

AIMS The aim of this study was to evaluate the efficacy of mitomycin C in reducing postoperative adhesions following strabismus surgery. METHODS This study was a prospective, single-center, interventional case series. We randomized 14 patients with restrictive strabismus to the mitomycin C group (7 patients) or to the control group (7 patients). We used mitomycin C intraoperatively for 5 min at a concentration of 0.2 mg/mL in the mitomycin group after adhesion release. We compared postoperative results using the forced duction test. RESULTS Compared to the control group, the mitomycin C group exhibited a better range of passive duction at all postoperative follow-up times; however, mitomycin C did not completely eliminate the problem of postoperative adhesions. Patients receiving mitomycin C did not report any complications during this study. CONCLUSIONS The intraoperative application of mitomycin C is a safe and effective adjunct to surgery in the treatment of restrictive strabismus.

[1]  R. Tandon,et al.  Effectiveness of mitomycin C in reducing reformation of adhesions following surgery for restrictive strabismus. , 2001, Journal of pediatric ophthalmology and strabismus.

[2]  El Sayed Rasheed.  Initial trabeculectomy with intraoperative mitomycin-C application in primary glaucomas. , 1999 .

[3]  S. Beatty,et al.  Trabeculectomy augmented with mitomycin C application under the scleral flap , 1998, The British journal of ophthalmology.

[4]  O. Cruz,et al.  Evaluation of mitomycin to limit postoperative adhesions in strabismus surgery. , 1996, Journal of pediatric ophthalmology and strabismus.

[5]  H. Grossniklaus,et al.  Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony. , 1994, American journal of ophthalmology.

[6]  J. Frucht‐Pery,et al.  The use of low-dose mitomycin C for prevention of recurrent pterygium. , 1994, Ophthalmology.

[7]  J. Frucht-Pery,et al.  Mitomycin C therapy for corneal intraepithelial neoplasia. , 1994, American journal of ophthalmology.

[8]  Holt Gr.  The future of wound healing in otolaryngology-head and neck surgery. , 1994 .

[9]  Y. Kitazawa,et al.  Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. , 1993, Ophthalmology.

[10]  R. Stamper,et al.  Long-term effects of mitomycin on filtering blebs. Lack of fibrovascular proliferative response following severe inflammation. , 1993, Archives of ophthalmology.

[11]  M. F. Smith,et al.  Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. , 1993, Ophthalmology.

[12]  P. Khaw,et al.  Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. , 1993, Archives of ophthalmology.

[13]  B. Chabner.  Pharmacologic principles of cancer treatment , 1982 .

[14]  A. Rosenbaum,et al.  New instrument for the quantitative determination of passive forced traction. , 1980, Ophthalmology.

[15]  R. Reinecke,et al.  Quantitative forced duction. , 1967, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.

[16]  Pamela J. Hines,et al.  Repair and Regeneration. , 2017, Science.